New York, USA
2016
Healthcare, Medical Imaging, Radiology, Cardiology, Neurology, Vascular Care
Aidoc is a healthcare technology company developing clinical artificial intelligence for hospitals and healthcare providers. Its technology initially focused on using AI to analyze medical images and identify suspected acute abnormalities that require attention. Since its founding in 2016, Aidoc has expanded from individual radiology AI algorithms into an enterprise clinical AI platform that connects algorithms, clinical data, and healthcare workflows.
The company’s technology now spans radiology, cardiology, neurovascular and vascular care, with applications for detection, triage, quantification, care coordination, patient management, and clinical trial enrollment. Its aiOS™ platform is designed to orchestrate these AI applications within existing hospital infrastructure.
Aidoc develops and deploys AI software that helps healthcare organizations analyze medical imaging and clinical information and incorporate AI-generated insights into existing workflows. In radiology, its algorithms can identify suspected findings such as intracranial hemorrhage, pulmonary embolism, vessel occlusions, fractures, and other abnormalities, helping prioritize cases for clinical review.
The company also provides tools for care coordination and patient follow-up, connecting findings from imaging and EHR data with the clinicians and teams responsible for subsequent care. Its platform integrates with systems such as PACS, EHRs, scheduling systems, reporting systems, and mobile workflows. Aidoc also provides AI-based patient identification for clinical trial enrollment.
Aidoc’s technology combines medical imaging AI, machine learning, clinical workflow software, data integration, and AI orchestration. Its aiOS™ clinical AI platform acts as an infrastructure layer that can run and coordinate multiple AI algorithms while connecting their outputs to existing hospital systems and clinical workflows.
aiOS™ can use imaging pixels, scan metadata, textual information, and other clinical data to determine which AI applications should process a case. It integrates with PACS, EHRs, mobile applications, worklists, scheduling systems, and communication tools, allowing AI results to be presented within established clinical workflows.
Aidoc is also developing CARE™ (Clinical AI Reasoning Engine), a clinical-grade foundation model trained on multimodal healthcare data. CARE™ is designed to support applications across multiple clinical tasks and modalities rather than being limited to a single condition or imaging use case. Aidoc has reported FDA-cleared applications powered by its foundation-model technology.
Aidoc is relevant to the emerging healthcare AI landscape because it represents a shift from individual medical-imaging algorithms toward enterprise clinical AI infrastructure. Rather than deploying each AI application as an isolated tool, its aiOS™ platform is designed to coordinate multiple algorithms and integrate their outputs into hospital workflows.
The company is also moving into foundation-model-based clinical AI through CARE™, extending AI beyond narrowly defined imaging tasks toward multimodal analysis and broader clinical applications. In 2026, Aidoc announced FDA-related milestones for foundation-model-powered solutions, including a clearance involving its CARE1™ technology and a submission covering multiple abdominal conditions.
aiOS™ is Aidoc’s enterprise clinical AI platform for deploying, orchestrating, integrating, and governing AI applications across healthcare systems. It can coordinate multiple algorithms and connect their results with clinical records and existing hospital infrastructure. AI orchestration is a central part of the platform, allowing different algorithms to be applied according to the clinical information available in a case.
CARE™ (Clinical AI Reasoning Engine) is Aidoc’s clinical-grade foundation model. It is trained on multimodal healthcare data and is designed to support multiple clinical AI tasks, including detection, measurement, risk assessment, and contextual interpretation. Aidoc has incorporated CARE™ technology into FDA-cleared clinical applications.
The Aidoc Widget provides a unified interface for viewing AI results from Aidoc and partner algorithms. It can display findings and key images, integrate with PACS worklists, and facilitate communication with downstream care teams.
First Read is an AI system designed to analyze chest radiographs and generate preliminary radiology report text. In June 2026, the FDA granted the product Breakthrough Device Designation; this designation is distinct from FDA clearance or approval.
Aidoc’s technology is primarily applied across medical imaging and clinical care workflows. In radiology, its AI can analyze CT and X-ray studies for suspected abnormalities and prioritize cases requiring attention. Applications include neurovascular conditions, pulmonary embolism, aortic disease, fractures, abdominal conditions, and other radiology findings.
The company also applies AI to cardiology through coronary artery calcification analysis and patient-management workflows. In vascular care, Aidoc supports pulmonary embolism, aortic disease, DVT, and related care coordination and follow-up processes.
Other applications include emergency department workflows, patient follow-up, multidisciplinary care coordination, and clinical trial patient identification.
Aidoc aiOS™ is an enterprise clinical AI platform that runs, orchestrates, integrates, and governs AI applications across healthcare systems. It connects AI analysis with systems such as PACS, EHRs, worklists, and clinical communication tools.
CARE™ stands for Clinical AI Reasoning Engine. It is Aidoc’s clinical-grade foundation model, designed to process multimodal healthcare data and support AI applications across different clinical tasks and conditions.
No. Radiology remains a major part of Aidoc’s technology, but its current platform also covers cardiology, neurovascular care, vascular care, care coordination, patient management, and clinical trial enrollment.
Aidoc’s solutions analyze medical imaging including CT and X-ray studies, with applications covering conditions involving the brain, chest, abdomen, cardiovascular system, blood vessels, and bones.
Yes. Aidoc states that its platform integrates with PACS, EHRs, scheduling systems, worklists, reporting systems, mobile applications, and other clinical IT infrastructure.
Have an update, correction, or additional information about this company? Help us keep the futureTEKnow company database up to date by submitting the latest company information.
futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.
© 2026 All Rights Reserved.